For Approved Qualified Domestic Institutional Investors in China

Global Life Sciences Fund

By understanding the science and business of health care, the strategy invests in companies addressing unmet medical needs or improving health care efficiencies

ISIN
IE00BFTCP959

NAV
CNH 22.13
As of 2021/11/30

1-Day Change
CNH -0.34 (-1.51%)
As of 2021/11/30

Morningstar Rating

Overview

INVESTMENT OBJECTIVE

The Fund aims to provide capital growth over the long term.

More

The Fund invests at least 80% of its assets in shares (also known as equities) selected for their growth potential and with a life sciences orientation. The Fund may invest in companies of any size, in any country.

Less

ABOUT THIS FUND

  • Looks to invest in companies addressing unmet medical needs or making the health care system more efficient
  • Aims to maintain a balanced portfolio across subsectors (pharmaceuticals, biotechnology, health care services, and medical devices)
  • An experienced team of specialists that seeks to understand the science and the business of health care

PORTFOLIO MANAGEMENT

Andy Acker, CFA

Global Life Sciences | Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Performance

Discrete Performance (%)
As of 2021/09/30
A2 HCNH
 
Quarter End
As of 2021/09/30
Sep-2020 - Sep-2021 Sep-2019 - Sep-2020 Sep-2018 - Sep-2019 Sep-2017 - Sep-2018 Sep-2016 - Sep-2017
A2 HCNH 18.23 29.60 -7.51 17.42 16.37
Cumulative Performance (%)
As of 2021/10/31
A2 HCNH
 
  Cumulative
  1MO 3MO 6MO YTD 1YR 3YR 5YR Since Inception
2014/10/03
A2 HCNH 4.60 3.87 7.86 8.40 25.82 60.92 124.02 138.80
CALENDAR YEAR RETURNS (%)
A2 HCNH
2016 2017 2018 2019 2020
A2 HCNH -9.52 24.75 2.96 27.10 24.60
FEE INFORMATION
Initial Charge 5.00%
Annual Charge 1.50%
Ongoing Charge
(As of 2021/06/30)
2.38%

Portfolio

Top Holdings (As of 2021/10/31)
% OF FUND
UnitedHealth Group Inc 4.75
AstraZeneca PLC 4.60
Merck & Co Inc 2.89
Roche Holding AG 2.77
Thermo Fisher Scientific Inc 2.75
Humana Inc 2.66
Abbott Laboratories 2.61
AbbVie Inc 2.56
Boston Scientific Corp 2.34
Danaher Corp 2.30
Total 30.23
Sector Allocation % OF FUND % OF FUND (As of 2021/10/31)
Health Care 99.69
Cash & Equivalents 0.31
Regional Allocations % OF FUND % OF FUND (As of October 31, 2021)
North America 81.43
Europe 16.58
Japan 1.41
Asia/Pacific Ex Japan 0.27
Cash & Equivalents 0.31

Documents